(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 8.34% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Teleflex's revenue in 2025 is $3,041,342,000.On average, 12 Wall Street analysts forecast TFX's revenue for 2025 to be $147,187,668,251, with the lowest TFX revenue forecast at $145,716,975,494, and the highest TFX revenue forecast at $147,906,199,263. On average, 12 Wall Street analysts forecast TFX's revenue for 2026 to be $161,956,863,500, with the lowest TFX revenue forecast at $153,587,716,202, and the highest TFX revenue forecast at $165,438,462,009.
In 2027, TFX is forecast to generate $169,521,215,407 in revenue, with the lowest revenue forecast at $161,343,555,585 and the highest revenue forecast at $175,448,135,059.